Zimmer Biomet Holdings Inc
NYSE:ZBH
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
US |
Zimmer Biomet Holdings Inc
NYSE:ZBH
|
24.5B USD | 24 | ||
US |
Abbott Laboratories
NYSE:ABT
|
182.6B USD | 32.4 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
132.5B USD | 66.7 | ||
US |
Stryker Corp
NYSE:SYK
|
123.5B USD | 36.7 | ||
IE |
Medtronic PLC
NYSE:MDT
|
107.2B USD | 25.5 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
104.5B USD | 59.2 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
67.6B USD | 55.5 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
57.2B EUR | 37.7 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
51.1B USD | 36.1 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 32.5 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
50B USD | 78.2 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.